Innovation Insight
By Richard Mark Kirkner
AMD is gene therapy’s emerging darling
Most programs in retinal disease still target inherited disorders, but both wet and dry forms of age-related macular degeneration are attracting interest.
Can patients take OCT home with them?
Early work with home-based optical coherence tomography shows patients can use it, but how good are the images?
DRI OCT Triton: One Doctor’s Experience
The imaging platform provides more detailed information and eases workflow in this retina specialist’s clinic.
Drilling Down Into Retina Robotic Surgery
Trial shows which steps take longer than manual surgery and the impact on involuntary hand movements.
Retina AI Platform Moves Forward
Autonomous artificial intelligence system aims to widen primary-care screening of diabetic retinopathy.
The Hypersonic Principle
A closer look at ‘the first major vitreous removal innovation in 40 years.’
Can Sirolimus Solve the Taper Puzzle?
SAKURA results point the way to successful tapering of steroids in noninfectious posterior uveitis.
A Marriage of Prosthetics, Optogenetics
An investigational neuroprosthetic device pairs with gene therapy to work around damaged photoreceptors.
Shaping Watson Computing for the Clinic
Cognitive imaging in ophthalmology could be about a year away. Here’s what it might look like.
25 Years On, OCT Looks To Future
Co-inventor David Huang, PhD, shares the next big thing for today’s big thing.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
